Clinical, laboratory features and prognosis of children receiving IgM-enriched immunoglobulin (3 days vs. 5 days) as adjuvant treatment for serious infectious disease in pediatric intensive care unit: a retrospective single-center experience (PIGMENT study)

INTRODUCTION: Although there are studies about sepsis treatment in different age groups, data on immunoglobulin-M (IgM)-enriched intravenous immunoglobulin use in pediatric intensive care units (PICUs) are limited. The aim of this study was to evaluate the clinical features and prognoses of children...

Full description

Saved in:
Bibliographic Details
Published in:Hum Vaccin Immunother
Main Authors: Abdullayev, Emin, Kilic, Omer, Bozan, Gurkan, Kiral, Eylem, Iseri Nepesov, Merve, Dinleyici, Ener Cagri
Format: Artigo
Language:Inglês
Published: Taylor & Francis 2020
Subjects:
Research Paper
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7482735/
https://ncbi.nlm.nih.gov/pubmed/32040371
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2019.1711298
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items